Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1Phase 1 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1NET 1Head & Neck 1Endocrine 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Neuroendocrine Tumors 1Mucositis 1Meningioma 1

Interventions

Cyclophosphamide 2067Radiotherapy 1986Cisplatin 1855Carboplatin 1559Gemcitabine 1454Paclitaxel 1320Bevacizumab 1318pembrolizumab 1236Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 978Magnetic Resonance Spectroscopy 969Nivolumab 936Rituximab 929Drug Therapy 914Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 815Blood Specimen Collection 815Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Lysine × Clear all
NCT07150806 2026-05-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Ohio State University Comprehensive Cancer Center

Phase 1/2 Recruiting
30 enrolled
CNS

Meningioma

NCT03478358 2022-08-31

Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Peking Union Medical College Hospital

Phase 1 Unknown
60 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT01155609 2013-05-17

L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer

University of Washington

Phase NA Completed
10 enrolled
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡